Does glucagon stimulation test help to predict autoimmunity in newly diagnosed non obese adults with diabetes?

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 7, 2012, Pages 428-434

  Rogowicz Frontczak, A ^a   Zozuliska Ziokiewicz D ^a   Niedwiecki, P ^a   Litwinowicz, M ^a   Wierusz Wysocka, B ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

antibodies; autoimmunity; diabetes

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUCAGON; GLUTAMATE DECARBOXYLASE ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCAGON BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROVOCATION TEST; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AUTOANTIBODIES; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCAGON; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MIDDLE AGED;

EID: 84863775184     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1308979     Document Type: Article

References (34)

1. Hosszufalusi N, Vatay A, Rajczy K et al. Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. Diabetes Care: 2003; 26 02 452 457 (Pubitemid 36929072)
2. Gottsater A, Landin-Olsson M, Fernlund P et al. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care: 1993; 16 06 902 910 (Pubitemid 23154174)
3. Knip M, Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev: 2008; 7 07 550 557
4. Schafer S A, Machicao F, Fritsche A et al. New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms. Diabetes Res Clin Pract: 2011; 93 01 S9 S24
5. Tuomi T, Carlsson A, Li H et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes: 1999; 48 01 150 157 (Pubitemid 29019367)
6. Turner R, Stratton I, Horton V et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet: 1997; 350 9087 1288 1293 (Pubitemid 28036638)
7. Wroblewski M, Gottsater A, Lindgarde F et al. Gender, autoantibodies, and obesity in newly diagnosed diabetic patients aged 40-75 years. Diabetes Care: 1998; 21 02 250 255 (Pubitemid 28079433)
8. Radtke M A, Midthjell K, Nilsen T I et al. Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Trondelag Health (HUNT) study. Diabetes Care: 2009; 32 02 245 250
9. Katulanda P, Shine B, Katulanda G W et al. Diabetes mellitus among young adults in Sri Lanka - role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study. Diabetologia: 2008; 51 08 1368 1374
10. Pozzilli P, Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care: 2001; 24 08 1460 1467 (Pubitemid 33716438)
11. Lee S H, Kwon H S, Yoo S J et al. Identifying latent autoimmune diabetes in adults in Korea: the role of C-peptide and metabolic syndrome. Diabetes Res Clin Pract: 2009; 83 02 e62 e65
12. Hawa M I, Thivolet C, Mauricio D et al. Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care: 2009; 32 01 160 164
13. Juneja R, Hirsch I B, Naik R G et al. Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes. Metabolism: 2001; 50 09 1008 1013 (Pubitemid 32904156)
14. Tfayli H, Bacha F, Gungor N et al. Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes: 2009; 58 03 738 744
15. Maruyama T, Shimada A, Kanatsuka A et al. Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report. Ann N Y Acad Sci: 2003; 1005 362 369 (Pubitemid 38507787)
16. Chaillous L, Bouhanick B, Kerlan V et al. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control. Diabetes Metab: 2010; 36 01 64 70
17. Desai M, Clark A. Autoimmune diabetes in adults: lessons from the UKPDS. Diabet Med: 2008; 25 02 30 34 (Pubitemid 352020093)
18. Tiberti C, Giordano C, Locatelli M et al. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2. Diabetes: 2008; 57 05 1276 1283
19. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care: 2010; 33 01 62 69
20. Chase H P, Cooper S, Osberg I et al. Elevated C-reactive protein levels in the development of type 1 diabetes. Diabetes: 2004; 53 10 2569 2573 (Pubitemid 39299263)
21. Bonifacio E, Mollenhauer U, Buuck D et al. C-reactive protein concentration is not related to islet autoimmunity status in offspring of parents with type 1 diabetes. Clin Immunol: 2005; 115 02 173 177 (Pubitemid 40693087)
22. Pietropaolo M, Barinas-Mitchell E, Kuller L H. The Heterogeneity of Diabetes. Diabetes: 2007; 56 05 1189 1197
23. Davis T M, Wright A D, Mehta Z M et al. Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70). Diabetologia: 2005; 48 04 695 702 (Pubitemid 40591225)
24. Bottazzo G F, Bosi E, Cull C A et al. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). Diabetologia: 2005; 48 04 703 708 (Pubitemid 40591226)
25. Huang G, Wang X, Li Z et al. Insulin autoantibody could help to screen latent autoimmune diabetes in adults in phenotypic type 2 diabetes mellitus in Chinese. Acta Diabetol: 2010
26. Rogowicz A, Litwinowicz M, Piaciski S et al. Does early insulin treatment decrease the risk of microangiopathy in non-obese adults with diabetes? Arch Med Sci: 2007; 2 129 135 (Pubitemid 47237978)
27. Desai M, Cull C A, Horton V A et al. GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77. Diabetologia: 2007; 50 10 2052 2060 (Pubitemid 47373841)
28. Thunander M, Thorgeirsson H, Torn C et al. beta-cell function and metabolic control in latent autoimmune diabetes in adults with early insulin versus conventional treatment: a 3-year follow-up. Eur J Endocrinol: 2010; 164 02 239 245
29. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med: 1993; 329 14 977 986
30. Epidemiology of Diabetes Interventions and Complications (EDIC) Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care: 1999; 22 01 99 111
31. Stratton I M, Adler A I, Neil H A et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ: 2000; 321 7258 405 412 (Pubitemid 30609442)
32. Groop L C, Bottazzo G F, Doniach D. Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes: 1986; 35 02 237 241 (Pubitemid 16121546)
33. Gale E A. Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia: 2005; 48 11 2195 2199 (Pubitemid 41618905)
34. Naik R G, Palmer J P. Latent autoimmune diabetes in adults (LADA). Rev Endocr Metab Disord: 2003; 4 03 233 241 (Pubitemid 37082196)